首页 > 市场调查报告书 > 製药

癌症

市场调查报告书

商品编码

1741434

肿瘤微环境市场按癌症类型、标靶、治疗、最终用户和地区划分

Tumor Microenvironment Market, By Cancer Type, By Target, By Therapy, By End User, By Geography

出版日期: 2025年03月27日 | 出版商:

Coherent Market Insights | 英文 160 Pages | 商品交期: 2-3个工作天内

价格

简介目录

肿瘤微环境市场规模在2025年估计为18.7亿美元，预计到2032年将达到43.7亿美元，2025年至2032年的年复合成长率（CAGR）为12.9%。

报告范围		报告详细信息
基准年	2024	2025年的市场规模	18.7亿美元
效能数据	从2020年到2024年	预测期	2025年至2032年
预测期：2025-2032年复合年增长率：	12.90%	2032年价值预测	43.7亿美元

肿瘤微环境是一个复杂的生态系统，由各种细胞和非细胞成分组成，它们相互作用，在肿瘤的发生和发展中起关键作用。这些成分包括免疫细胞、纤维母细胞、细胞外基质、讯号分子等。了解肿瘤微环境对于开发有效治疗癌症的标靶治疗至关重要。近年来，肿瘤微环境研究引起了广泛关注，人们认识到癌细胞与其周围环境之间动态相互作用的重要性。目前已清楚，肿瘤微环境影响各种过程，包括血管生成、免疫反应、转移和抗药性。

市场动态：

受多种因素推动，肿瘤微环境市场预计将在未来几年内实现显着成长。其中一个主要驱动因素是全球癌症发生率的上升。根据世界卫生组织 (WHO) 2020 年的数据，癌症是全球主要死亡原因之一，每年约有 1,000 万例新病例和 600 万人死亡。这导致对用于理解和治疗癌症的先进方法的需求不断增长，从而推动了市场的成长。

然而，高昂的研发成本、严格的监管要求以及在肿瘤微环境研究中使用动物模型所带来的伦理问题等因素可能会抑制市场的成长。此外，熟练专家的缺乏以及调查方法缺乏标准化也可能对市场成长构成挑战。

儘管面临这些挑战，肿瘤微环境市场仍蕴藏着巨大的成长机会。多光子显微镜和活体成像等成像技术的进步，使研究人员能够即时、高解析度地研究肿瘤微环境。此外，个人化医疗的兴起和精准肿瘤学的日益关注，催生了对能够洞察肿瘤微环境的生物标誌物的需求，这进一步推动了市场的成长。

此外，市场参与者正在采取合作等无机策略，预计这将在预测期内推动全球肿瘤微环境市场的成长。例如，2023年3月20日，德国生物技术公司BioNTech SE和临床阶段生物製药公司OncoC4, Inc.宣布，双方已达成全球独家许可和合作协议，以开发和商业化OncoC4的下一代抗CTLA-4单克隆抗体候选药物ONC-392，作为多种癌症适应症的单一疗法或联合治疗。 CTLA-4是一种透过多种机制抑制免疫细胞活性的分子。 OncoC4的CTLA-4候选抗体ONC-392旨在消除肿瘤微环境中的免疫抑制T细胞（调节性T细胞，「Tregs」），并保护健康组织中的Tregs。

本研究的主要特点

本报告对全球肿瘤微环境市场进行了详细分析，并以 2024 年为基准年，提供了 2025 年至 2032 年预测期内的市场规模和年复合成长率（CAGR%）。
它还揭示了各个领域的潜在商机，并说明了该市场的引人注目的投资提案矩阵。
它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的重要见解。
它根据公司亮点、产品系列、关键亮点、财务表现和策略等参数，介绍了全球肿瘤微环境市场的主要企业概况。
本报告的见解将使负责人和企业经营团队能够就未来的产品发布、新兴趋势、市场扩张和行销策略做出明智的决策。
全球肿瘤微环境市场报告迎合了该行业的各个相关人员，例如投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
透过分析全球肿瘤微环境市场中使用的各种策略矩阵，相关人员将能够做出决策。

Thermo Fisher Scientific
Illumina
Danaher Corporation
Merck KGaA
BD Biosciences
Promega Corporation
Bio-Techne Corporation
Bio-Rad Laboratories
Hoffmann-La Roche Ltd
QIAGEN NV
Sartorius AG
PerkinElmer
Miltenyi Biotec
Cell Signaling Technology
BioLegend
Abcam
Takara Bio
Fluidigm Corporation
NanoString Technologies
10x Genomics
Bethyl Laboratories

第 11 章章节

调查方法
关于出版商

简介目录

Product Code: CMI6238

Tumor Microenvironment Market is estimated to be valued at USD 1.87 Bn in 2025 and is expected to reach USD 4.37 Bn by 2032, growing at a compound annual growth rate (CAGR) of 12.9% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 1.87 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	12.90%	2032 Value Projection:	USD 4.37 Bn

The tumor microenvironment is a complex ecosystem consisting of various cellular and non-cellular components that interact with each other and play a crucial role in tumor development and progression. These components include immune cells, fibroblasts, blood vessels, the extracellular matrix, and signaling molecules. Understanding the tumor microenvironment is essential for developing targeted therapies that can effectively treat cancer. The study of the tumor microenvironment has gained significant attention in recent years, as researchers have realized the importance of this dynamic interaction between tumor cells and their surroundings. It is now evident that the tumor microenvironment can influence various processes, such as angiogenesis, immune response, metastasis, and drug resistance.

Market Dynamics:

The tumor microenvironment market is expected to witness significant growth in the coming years, driven by several factors. One of the major drivers is the increasing incidence of cancer worldwide. According to the World Health Organization (WHO), 2020, cancer is one of the leading causes of death globally, with approximately 10 million new cases and 6 million deaths reported annually. This has led to a substantial demand for advanced methods to understand and treat cancer, thereby driving market growth.

However, market growth can be restrained by factors, such as the high cost of research and development, stringent regulatory requirements, and ethical concerns related to the use of animal models in tumor microenvironment studies. Additionally, the limited availability of skilled professionals and the lack of standardization in research methodologies can pose challenges to market growth.

Despite these challenges, the tumor microenvironment market offers significant opportunities for growth. Technological advancements in imaging techniques, such as multiphoton microscopy and intravital imaging, have enabled researchers to study the tumor microenvironment in real-time and high resolution. Moreover, the emergence of personalized medicine and the increasing focus on precision oncology have created a demand for biomarkers that can provide insights into the tumor microenvironment, further driving market growth.

Moreover, market players are engaged in conducting inorganic strategies such as collaborations, and this is expected to increase the growth of the global tumor microenvironment market over the forecast period. For instance, on March 20, 2023, BioNTech SE, a German biotechnology company and OncoC4, Inc., a clinical-stage biopharmaceutical company, announced that they had entered into an exclusive worldwide license and collaboration agreement to develop and commercialize OncoC4's next-generation anti-CTLA-4 monoclonal antibody candidate, ONC-392, as monotherapy or combination therapy in various cancer indications. CTLA-4 is a molecule that inhibits the activity of immune cells via various mechanisms. OncoC4's CTLA-4 antibody candidate, ONC-392, aims to delete immunosuppressive T cells (regulatory T cells, "Tregs") in the tumor microenvironment but spare Tregs in healthy tissues.

Key features of the study:

This report provides in-depth analysis of the global tumor microenvironment market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global tumor microenvironment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Thermo Fisher Scientific, Illumina, Danaher Corporation, Merck KGaA , BD Biosciences, Promega Corporation, Bio-Techne Corporation , Bio-Rad Laboratories, F. Hoffmann-La Roche Ltd, QIAGEN N.V., Sartorius AG, PerkinElmer, Miltenyi Biotec, Cell Signaling Technology, BioLegend, Abcam, Takara Bio, Fluidigm Corporation, NanoString Technologies, 10x Genomics, and Bethyl Laboratories
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global tumor microenvironment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global tumor microenvironment market

Detailed Segmentation:

By Cancer Type
- Lung Cancer
- Colorectal Cancer
- Breast Cancer
- Prostate Cancer
- Bladder Cancer
- Others (Melanoma, Kidney cancer, Ovarian cancer etc.)
By Target
- T Cells
- Tumor-Associated Macrophages
- Myeloid-Derived Suppressor Cells
- Cancer-Associated Fibroblasts
- Regulatory T Cells
- Others (Tumor-associated neutrophils, Dendritic cells etc.)
By Therapy:
- Monoclonal Antibodies
- Cytokines
- Cancer Vaccines
- Oncolytic Viruses
- Adoptive Cell Therapies
- Others (Gene therapies, Immunomodulators,Checkpoint inhibitors etc.)
By End User:
- Biopharmaceutical Companies
- Hospitals
- Diagnostic Laboratories
- Research Institutes
- Contract Research Organizations (CROs)
- Others (Academic Institutes and Others)
By Region
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
Company Profiles
- Thermo Fisher Scientific
- Illumina
- Danaher Corporation
- Merck KGaA
- BD Biosciences
- Promega Corporation
- Bio-Techne Corporation
- Bio-Rad Laboratories
- F.Hoffmann-La Roche Ltd
- QIAGEN N.V.
- Sartorius AG
- PerkinElmer
- Miltenyi Biotec
- Cell Signaling Technology
- BioLegend
- Abcam
- Takara Bio
- Fluidigm Corporation
- NanoString Technologies
- 10x Genomics
- Bethyl Laboratories

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Tumor Microenvironment, By Cancer Type
- Market Tumor Microenvironment, By Target
- Market Tumor Microenvironment, By Therapy
- Market Tumor Microenvironment, By End User
- Market Tumor Microenvironment, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Increasing cancer prevalence
- High costs associated with reagents
- Adoption of AI and machine learning
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Tumor Microenvironment Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Tumor Microenvironment Market , By Cancer Type, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
Lung Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Colorectal Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Breast Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Prostate Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Bladder Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Others (Melanoma, Kidney cancer, Ovarian cancer etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

6. Tumor Microenvironment Market , By Target, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
T Cells
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Tumor-associated Macrophages
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Myeloid-Derived Suppressor Cells
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Cancer-Associated Fibroblasts
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Regulatory T Cells
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Others (Tumor-associated neutrophils, Dendritic cells etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

7. Tumor Microenvironment Market , By Therapy, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Monoclonal Antibodies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Cytokines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Cancer Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Oncolytic Viruses
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Adoptive Cell Therapies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Others (Gene therapies, Immunomodulators,Checkpoint inhibitors etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

8. Tumor Microenvironment Market , By End User, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Biopharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Diagnostic Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Contract Research Organizations (CROs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Others (Academic Institutes and Others)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

9. Tumor Microenvironment Market , By Region, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, By Country, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Country 2021 -2032
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapy, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapy, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapy, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapy, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East & Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapy, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
  - GCC Countries
  - Israel
  - South Africa
  - North Africa
  - Central Africa
  - Rest of Middle East

10. Competitive Landscape

Thermo Fisher Scientific
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Illumina
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Danaher Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Merck KGaA
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
BD Biosciences
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Promega Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Bio-Techne Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Bio-Rad Laboratories
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Hoffmann-La Roche Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
QIAGEN N.V.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Sartorius AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
PerkinElmer
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Miltenyi Biotec
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Cell Signaling Technology
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
BioLegend
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Abcam
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Takara Bio
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Fluidigm Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
NanoString Technologies
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
10x Genomics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Bethyl Laboratories
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Analyst Views

11. Section

Research Methodology
About us

02-2729-4219

+886-2-2729-4219

License/价格

肿瘤微环境市场按癌症类型、标靶、治疗、最终用户和地区划分